Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김대기 | * |
dc.date.accessioned | 2018-05-02T08:15:42Z | - |
dc.date.available | 2018-05-02T08:15:42Z | - |
dc.date.issued | 2004 | * |
dc.identifier.issn | 0960-894X | * |
dc.identifier.other | OAK-2160 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/242775 | - |
dc.description.abstract | A series of 2-pyridinyl-[1,2,3]triazoles have been synthesized and evaluated for their ALK5 inhibitory activity in the luciferase reporter assays. Compound 8d showed significant ALK5 inhibition (SBE-luciferase activity, 25%; p3TP-luciferase activity, 17%) at a concentration of 5μM that is comparable to that of SB-431542 (SBE-luciferase activity, 21%; p3TP-luciferase activity, 12%), but weak p38α MAP kinase inhibition (13%) at a concentration of 10μM that is much lower than that of SB-431542 (54%). © 2004 Elsevier Ltd. All rights reserved. | * |
dc.language | English | * |
dc.title | Synthesis and biological evaluation of novel 2-pyridinyl-[1,2,3]triazoles as inhibitors of transforming growth factor β1 type 1 receptor | * |
dc.type | Article | * |
dc.relation.issue | 10 | * |
dc.relation.volume | 14 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 2401 | * |
dc.relation.lastpage | 2405 | * |
dc.relation.journaltitle | Bioorganic and Medicinal Chemistry Letters | * |
dc.identifier.doi | 10.1016/j.bmcl.2004.03.024 | * |
dc.identifier.wosid | WOS:000221316000003 | * |
dc.identifier.scopusid | 2-s2.0-1942534588 | * |
dc.author.google | Kim D.-K. | * |
dc.author.google | Kim J. | * |
dc.author.google | Park H.-J. | * |
dc.contributor.scopusid | 김대기(35083694200) | * |
dc.date.modifydate | 20240118164500 | * |